Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.70 EUR
−579.68 M EUR
0.00 EUR
161.88 M
About Revolution Medicines, Inc.
Sector
Industry
CEO
Mark A. Goldsmith
Website
Headquarters
Redwood City
Founded
2004
FIGI
BBG01JLTCD26
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
Related stocks
RVMD - a biotech that ending consolidation?
Fundamentals: Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment. Average 1 year target from analysts = 54.
Technical: To allow the stock some fluctuation the stop
RVMDClassics of the genre. A young and beautiful company that has everything ready to make friends with you, that is, the Triangle pattern, which has already been formed and broken up. Now the price will move along the indicated arrows and reach the main target of the trade of 72.44 dollars (an increase
RVMD Revolution Medicines, Inc. - LONG$RVMD still very cheap imo...buy and hold, LT hold. Next MRTX ?
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where 42Z is featured.
Mid-weight oncology stocks: The dark horses of cancer research
18 No. of Symbols
See all sparks
Frequently Asked Questions
The current price of 42Z is 32.20 EUR — it has increased by 1.26% in the past 24 hours. Watch REVOLUTION MEDICINES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange REVOLUTION MEDICINES INC stocks are traded under the ticker 42Z.
42Z stock has fallen by −3.01% compared to the previous week, the month change is a −5.29% fall, over the last year REVOLUTION MEDICINES INC has showed a −25.46% decrease.
We've gathered analysts' opinions on REVOLUTION MEDICINES INC future price: according to them, 42Z price has a max estimate of 74.90 EUR and a min estimate of 48.51 EUR. Watch 42Z chart and read a more detailed REVOLUTION MEDICINES INC stock forecast: see what analysts think of REVOLUTION MEDICINES INC and suggest that you do with its stocks.
42Z stock is 1.89% volatile and has beta coefficient of 1.00. Track REVOLUTION MEDICINES INC stock price on the chart and check out the list of the most volatile stocks — is REVOLUTION MEDICINES INC there?
Today REVOLUTION MEDICINES INC has the market capitalization of 6.01 B, it has increased by 0.32% over the last week.
Yes, you can track REVOLUTION MEDICINES INC financials in yearly and quarterly reports right on TradingView.
REVOLUTION MEDICINES INC is going to release the next earnings report on Aug 6, 2025. Keep track of upcoming events with our Earnings Calendar.
42Z earnings for the last quarter are −1.04 EUR per share, whereas the estimation was −1.01 EUR resulting in a −3.61% surprise. The estimated earnings for the next quarter are −0.95 EUR per share. See more details about REVOLUTION MEDICINES INC earnings.
REVOLUTION MEDICINES INC revenue for the last quarter amounts to 0.00 EUR, despite the estimated figure of 0.00 EUR. In the next quarter, revenue is expected to reach 23.37 M EUR.
42Z net income for the last quarter is −197.27 M EUR, while the quarter before that showed −187.95 M EUR of net income which accounts for −4.96% change. Track more REVOLUTION MEDICINES INC financial stats to get the full picture.
No, 42Z doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 27, 2025, the company has 534 employees. See our rating of the largest employees — is REVOLUTION MEDICINES INC on this list?
Like other stocks, 42Z shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REVOLUTION MEDICINES INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REVOLUTION MEDICINES INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REVOLUTION MEDICINES INC stock shows the sell signal. See more of REVOLUTION MEDICINES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.